Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco IPO plans

Executive Summary

Merck pharmacy benefit management subsidiary is understood to be looking for a November date to complete its delayed initial public offering. Medco Health Solutions withdrew its IPO registration in July, citing market conditions (1"The Pink Sheet" July 15, p. 28). Company has pledged to complete the IPO by summer 2003 at the latest...

You may also be interested in...



Medco’s Washington D.C. office

Medco is searching for a head of its new Washington, D.C. office, which could open as early as November. Merck's Washington office currently handles Medco's federal lobbying, but Merck plans to spin off the pharmacy benefit management subsidiary, which could also happen in November (1"The Pink Sheet" Sept. 23, In Brief)...

Medco IPO Delay: Merck Trades Gross Margin For Cloudy Rebate Calculations

Merck's gross margins would be about five percentage points higher if the company excluded copayments for Medco-managed prescriptions from its revenue line

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel